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Abstract
Dysregulation of the nociceptin (N/OFQ) system has been implicated in alcohol abuse and 
alcoholism and growing evidence suggests that targeting this system may be beneficial for treating 
alcoholism. To further explore the treatment target potential of the N/OFQ system, the novel non-
peptide, small-molecule N/OFQ (NOP) agonist MT-7716, (R)-2-{3-[1-(Acenaphthen-1-
yl)piperidin-4-yl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-N-methylacetamide hydrochloride 
hydrate, was examined for its effects on ethanol self-administration and stress induced 
reinstatement of alcohol seeking in non-dependent and post-dependent rats. Male Wistar rats were 
trained to self-administer ethanol and then made ethanol dependent via repeated intragastric 
ethanol intubation. The effects of MT-7716 (0.3 and 1 mg/kg; PO) on alcohol self-administration 
were determined two weeks following dependence induction, when baseline self-administration 
was restored. Effects of MT-7716 on stress-induced reinstatement were tested in separate cohorts 
of rats, one and three weeks post-withdrawal. MT-7716 reduced alcohol self-administration and 
stress-induced reinstatement of alcohol seeking in post-dependent rats, but was ineffective in non-
dependent animals. Moreover, the prevention of stress-induced reinstatement by MT-7716 was 
more pronounced at 3 weeks post-dependence. The results further confirm treatment target 
potential for the NOP receptor and identify non-peptide NOP agonists as promising potential 
treatment drugs for alcohol abuse and relapse prevention. The findings also support dysregulation 
of the N/OFQ system as a factor in alcohol seeking and reinforcement.
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Introduction
The nociceptin/orphanin FQ (N/OFQ) receptor (NOP) also referred to as opioid receptor-
like 1 (ORL1), was identified as the fourth member of the opioid receptor family (Bunzow 
et al., 1994; Mollereau et al., 1994). N/OFQ is a heptadecapeptide that binds with high 
affinity its receptor, but does not bind to mu (MOP), delta (DOP) and or kappa (KOP) 
opioid receptors. N/OFQ and NOP are present in the cortex, amygdala, bed nucleus of the 
stria terminalis (Neal et al., 1999), areas that regulate the motivating actions of drugs of 
abuse (Eckardt et al., 1998; Everitt and Wolf, 2002; Martin-Fardon et al., 2010; Wise, 1998). 
Dysregulation of the nociception system has been widely implicated as a factor in high 
alcohol intake (Economidou et al., 2008; Martin-Fardon et al., 2010). For example, higher 
expression of N/OFQ and NOP receptor mRNAs in the central nucleus of the amygdala 
(CeA) contributes to excessive alcohol intake in Marchigian Sardinian Alcohol Preferring 
(msP) rats in which genetic selection for high ethanol preference is correlated with anxiety 
and hypersensitivity to stress (Ciccocioppo et al., 2006; Economidou et al., 2008). In 
addition to the role of increased NOP receptor messenger RNA expression and binding in 
predisposition to high alcohol intake, up-regulation of this system by chronic ethanol may be 
a factor in the perseveration of alcohol seeking and use. In support of this hypothesis, Wistar 
rats with a history of ethanol dependence show increased expression of NOPs that is 
associated with both increased alcohol intake and anxiety-like behavior (Roberto and 
Siggins, 2006). Moreover, in Wistar rats, intracerebroventricular administration of N/OFQ 
reduces ethanol intake following a history of ethanol dependence but not in the 
nondependent state, and produces greater anxiolytic effects in the post-dependent than in the 
non-dependent state (Martin-Fardon et al., 2010).
Consistent with a role of the nociception system in alcohol abuse, pharmacological findings 
implicate the N/OFQ system as a highly promising target for treating alcohol addiction. 
N/OFQ reduces alcohol intake and alcohol self-administration in alcohol preferring rats 
(Ciccocioppo et al., 2004; Ciccocioppo et al., 1999), attenuates alcohol-induced conditioned 
place preference, and reduces reinstatement of alcohol seeking induced by stress or alcohol-
related cues (Ciccocioppo et al., 2004; Martin-Fardon et al., 2000). N/OFQ also has 
anxiolytic-like and anti-stress actions (Aujla et al., 2013) and attenuates protracted alcohol 
withdrawal symptoms in rats (Economidou et al., 2011).
Recently, a blood brain barrier penetrating NOP receptor agonist MT-7716, hydrochloride of 
W-212393 (Teshima et al., 2005) has become available, providing a suitable 
pharmacological tool to study the treatment target potential of the nociception system with 
direct translational implications. MT-7716 exhibits high affinity for human NOP receptors 
expressed in HEK293 cells (Kallupi et al., 2014). The affinity of MT-7716 for the NOP is 
similar to that of the endogenous agonist N/OFQ and is in the nM range (Kallupi et al., 
2014). The NOP agonistic activity of MT-7716 was evaluated by GTPγ35S binding to 
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human NOP expressed in HEK293 cells. In this preparation MT-7716 demonstrated full 
agonism at NOP receptor (Kallupi et al., 2014). Here, the effects of this NOP agonist were 
examined on two processes relevant for alcohol addiction: ethanol self-administration and 
stress induced reinstatement of ethanol seeking in rats with or without a history of ethanol 
dependence. Since time-dependent changes in nociception and NOP gene expression 
following ethanol withdrawal have recently been reported (Aujla et al., 2013), a secondary 
goal was to establish the effects of MT-7716 on ethanol self-administration and 
reinstatement at different time points following withdrawal.
Materials and Methods
Animals
Male Wistar rats (Charles River, Wilmington, MA, USA). Rats (N = 156) were housed two 
per cage on a reverse 12:12 h light/dark cycle (lights off at 8:00 a.m.) in a temperature (20–
22°C) and humidity (45–55%) controlled vivarium with ad libitum access to tap water and 
food pellets (PJ Noyes Company, Inc, Lancaster, NH). All procedures were conducted in 
strict adherence to the National Institute of Health Guide for the Care and Use of 
Laboratory Animals and were approved by the Institutional Animal Care and Use 
Committee of The Scripps Research Institute. At the time of testing, the rats’ body weight 
ranged between 350 and 400 g.
Drugs
MT-7716 was synthesized at Mitsubishi Tanabe Pharma Corporation (Japan) and dissolved 
in distilled water by sonication in a heated bath (45–60°C). Alcohol drinking solution 10% 
(w/v) was prepared by dilution of ethanol 95 % (w/v) in water.
Equipment
All training and testing was conducted in standard operant conditioning chambers (Med 
Associate, St Albans, VT) located in sound-attenuating, ventilated environmental cubicles. 
Each chamber was equipped with a drinking reservoir (volume capacity: 0.15 ml) positioned 
4 cm above the grid floor in the center of the front panel of the chamber, and two retractable 
levers located 3 cm to the right or the left of the drinking receptacle. Visual stimuli were 
presented via a cue light located on the front panel. A microcomputer controlled the delivery 
of fluids, presentation of visual stimuli, and recording of the behavioral data.
Ethanol Self-administration training
Rats were trained to self-administer 10% (w/v) alcohol in 30-min daily sessions on a fixed-
ratio 1 (FR 1) schedule of reinforcement, where each response resulted in delivery of 0.1 ml 
fluid (Weiss et al., 1993). Responses at the right, active lever were initially reinforced by 0.1 
ml of saccharin (0.2% w/v) on a FR 1 schedule. After acquisition, ethanol (5% w/v) was 
added to the saccharin solution. During subsequent training, ethanol concentrations were 
gradually raised to 10% (w/v), while saccharin was slowly eliminated. A second but inactive 
lever then was introduced at which responses were recorded but had no programmed 
consequences.
de Guglielmo et al. Page 3
Addict Biol. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Ethanol dependence induction
Once stable 10% (w/v) ethanol self-administration was obtained, three groups of rats were 
made ethanol dependent via repeated intragastric ethanol intubation as previously described 
(Braconi et al., 2010) with modifications. Briefly, ethanol solution (final concentration 25% 
w/v) was made up in a dietary supplement (Boost®, Nestlé, Florham Park, NJ) and 
intubated four times per day for 5 consecutive days (11 g/kg of alcohol per day), with each 
daily dose administered at 4 h intervals (Figure 1A). Non-dependent controls received 
intragastric administration of Boost® vehicle at volumes and times identical to those in 
ethanol-treated rats. Blood alcohol levels (BALs) were determined from tail blood samples 
(200 μl) taken 1 h after the first (Bleed 1) and second (Bleed 2) intragastric administration 
on day 4. Behavioral signs of withdrawal were measured on day 5, 12 h after the final 
ethanol intubation on the previous day, before the first alcohol (or vehicle) administration, 
using a rating scale adapted from (Macey et al., 1996). Withdrawal signs scored included: 
ventromedial limb retraction (VLR), irritability to touch (vocalization), tail rigidity, 
abnormal gait and body tremors. Each sign was assigned a score of 0–2, based on the 
following severity scale: 0 = no sign, 1 = moderate, 2 = severe. The sum of the four 
observation scores (0–8) was used as a quantitative measure of withdrawal severity.
Effect of MT-7716 on alcohol self administration in post-dependent and non-dependent 
rats
Wistar rats (N=19) were trained to self-administer 10% (w/v) alcohol until stable self-
administration (± 10% over the last three sessions) was established. The following day, rats 
were divided into two groups for dependence induction (N=9; Fig. 1A) vs. vehicle treatment 
(N=10; Fig. 1A). Two days after completion of dependence induction (or control) 
procedures, daily ethanol self-administration sessions resumed until stable levels of intake 
were re-established. Animals were injected by gavage with MT-7716 (0.0, 0.3 or 1.0 mg/
kg), 1 hour before the test session. Each rat was tested with all MT-7716 doses according to 
a Latin square design, with 2–3 baseline EtOH self-administration sessions between tests.
Effect of MT-7716 on stress-induced reinstatement in post-dependent and non-dependent 
rats
Wistar rats were trained to self-administer 10% (w/v) alcohol until stable responding was 
established, followed by ethanol dependence induction. Rats then were divided into two 
groups for testing following 1 or 3 weeks of ethanol withdrawal. Rats in the 1-week post-
withdrawal group were subjected to 30-min extinction sessions for 4 consecutive days (2 
sessions per day) beginning forty-eight hours after completion of ethanol dependence 
induction. Extinction sessions were identical to the EtOH self-administration sessions, 
except that responses at the active lever activated the syringe pump but did not result in any 
EtOH delivery.
For rats in the 3-week post-withdrawal group, extinction sessions began 2 weeks after 
completion of ethanol dependence induction. One day after the final extinction session, 
nondependent and post-dependent rats were divided into three groups for testing the effects 
of MT-7716 (0.0, 0.3 and 1.0 mg/kg, PO) on reinstatement of ethanol seeking induced by 
footshock stress (15-min, variable intermittent electric foot shock, 0.5 mA; duration, 0.5 sec; 
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mean shock interval, 40 sec; range, 10–70 sec), administered through the grid floor of the 
operant chambers. Each animal was tested with only one dose of MT-7716 or vehicle 
(administered 1 hour before session onset) according to a between-subjects design. Two 
minutes following termination of foot-shock, levers were extended and responses were 
recorded for 30 minutes.
Statistical Analysis
The effect of MT-7716 on alcohol self-administration was analyzed by two-way ANOVA 
with one factor within (treatment) and one factor between (intoxication condition). 
Reinstatement data were analyzed by three-way Anova with time (1 week vs 3 weeks), 
dependence (non-dependent vs post-dependent) as between factors and condition (extinction 
vs relapse) as within factor. The effect of MT-7716 on stress-induced reinstatement of 
alcohol seeking was analyzed by three-way ANOVA with three factors between (treatment, 
time and intoxication condition). Where appropriate, ANOVAs were followed by Protected 
Least Significant Difference (PLSD) post hoc tests. Withdrawal signs were analyzed by the 
nonparametric Mann-Whitney U statistic.
Results
Blood alcohol levels and withdrawal ratings
Mean (± SEM) blood alcohol levels (BALs) measured on day 4 of dependence induction 
were elevated (Bleed 1: 256.3 ± 12.51 mg/100 ml, Bleed 2: 351.1 ± 10.9 mg/100 ml). In the 
morning of day 5, post-dependent rats showed overt withdrawal signs (Figure 1B) with 
significant increases in ventromedial limb retraction (VLR; Mann-Whitney, U = 1937.6, p< 
0.001), tail rigidity (U = 2143.2; p< 0.001), abnormal gait (U = 787.0; p < 0.001), and body 
tremors (U = 1224.3; p < 0.001). The sum of the five rating scores revealed the presence of 
significant overall withdrawal severity (U = 2545.8; p< 0.001; Figure 2 insert).
Effects of MT-7716 on alcohol self-administration in post-dependent and non-dependent 
rats
The mean (± SEM) number of responses before drug testing was similar in non-dependent 
(43.6 ± 5.6) and post-dependent (44.6 ± 5.7) rats. As well, mean (± SEM) of responses 
following vehicle administration were similar in non-dependent (38.8 ± 3.1) and post-
dependent (42.8 ± 3.3) animals. MT-7716 reduced ethanol self-administration selectively in 
post-dependent rats (Figure 2). This effect was confirmed by the ANOVA with a main effect 
of dose [F (2,17) = 8.32, p < 0.01] and a dose x groups (non-dependent vs, post-dependent) 
interaction [F (2,34) = 5.01; p < 0.05]. PLSD post hoc tests verified that MT-7716 
significantly reduced alcohol self-administration in post-dependent rats at both 0.3 (p<0.05 
vs vehicle) and 1 mg/kg (p<0.001vs vehicle). Inactive lever responses remained negligible 
and unaltered by MT-7716.
Importantly, baseline alcohol self-administration across the three test days remained stable 
in both nondependent [F (2,9) = 1.397; NS] and post-dependent [F (2,8) = 0.43; NS] animals 
(Figure 2, insert).
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Effect of MT-7716 on stress-induced reinstatement of alcohol seeking in post-dependent 
and non-dependent rats
To evaluate the reinstatements, comparison of extinction vs MT-7716 vehicle treated groups 
were analyzed. A three way Anova with time (1 week vs 3 weeks), dependence (non-
dependent vs post-dependent) as between factors and condition (extinction vs reinstatement) 
as within factor showed main effects of condition [F(1,46)=119.85; p<0.0001] and of 
dependence [F(1,46)=3.68; p<0.05]. A significant time x dependence interaction was also 
observed [F(1,46)=5.23; p<0.05]. Compared to extinction, footshock elicited significant 
(p<0.001) reinstatement of lever pressing in both vehicle treated non-dependent and post-
dependent rats (Fig 3A and 3B). Post hoc analysis of time x dependence interaction showed 
that at 3 weeks, reinstatement of responding in post-dependent rats was significantly higher 
(p<0.05) than in the non-dependent group (Fig 3B). Inactive lever responses remained 
negligible and unaltered by footshock stress.
Analysis of the effects of MT-7716 by three-way ANOVA revealed a main effect for 
treatment (MT-7716 doses) [F(2,127)=13,11; p<0.001], time [F(1,127)=6.80; p<0.05] and 
treatment x dependence interaction [F(2,127)=4.95; p<0.01]. Post hoc analysis of treatment 
x dependence interaction revealed that administration of MT-7716 significantly reduced 
footshock stress-induced reinstatement at 1 week and at 3 weeks only in the post-dependent 
group (p<0.001; Fig 3A and 3B). Inactive lever responses remained negligible and unaltered 
by MT-7716.
Discussion
The results confirm that activation of NOP receptors by the synthetic agonist MT-7716, like 
the endogenous agonist N/OFQ (Ciccocioppo et al., 2004; Martin-Fardon et al., 2000), 
reduces alcohol self-administration and stress-induced reinstatement of alcohol seeking. 
Both effects were, however, observed only in rats with a history of ethanol dependence. 
Even though the NOP agonist was behaviorally inert in ethanol nondependent animal in 
post-dependent rats, MT-7716 prevented footshock-induced reinstatement following one or 
three weeks of withdrawal similarly. Both observations are suggestive of ethanol-induced 
neuroadaptive changes in N/OFQ-NOP functioning whereby rats with a history of ethanol 
dependence become responsive to NOP receptor agonist treatments.
In the alcohol self-administration tests, vehicle-treated postdependent and nondependent rats 
showed similar levels of ethanol-reinforced responding, in contrast to previous reports of 
increased alcohol intake in ethanol postdependent rats (Roberts et al., 2000; Rodd et al., 
2006; Valdez et al., 2002). However, in these previous studies, rats had been allowed to self-
administer ethanol during acute withdrawal. Therefore, the lack of increased self-
administration in post-dependent rats in the present study may be attributable to the lack of 
opportunity to self-administer alcohol during withdrawal. In spite of the absence of 
differences in alcohol intake, MT-7716 reduced alcohol self-administration only in rats with 
a history of dependence. This observation is in agreement with previous findings showing 
that N/OFQ (administered ICV) does not reduce alcohol self-administration in 
nondependent Wistar rats, although the peptide effectively reduces alcohol self-
administration in nondependent Marchigian Sardinian Alcohol-Preferring (msP) rats 
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(Economidou et al., 2008), a line of rats with dysregulated N/OFQ function (Ciccocioppo et 
al., 2006). Notably, several lines of evidence indicate that the msP rat line has innate 
characteristics resembling rats with a history of chronic alcohol intoxication and has been 
proposed as a postdependent phenotype (Ciccocioppo et al., 2006; Gozzi et al., 2013; 
Hansson et al., 2007; Hansson et al., 2006).
Stress-regulatory systems can undergo time-dependent biphasic functional changes 
following ethanol withdrawal with corresponding biphasic changes in the behavioral effects 
of stress challenges (Zhao et al., 2007; Zorrilla et al., 2001).
Similarly, we have previously observed that nociception produces opposite effects on stress-
induced experimental anxiety at 7 vs. 21 days following alcohol withdrawal (Aujla et al., 
2013). Guided by these findings, the effects of MT-7716 on stress-induced reinstatement in 
the present study were probed for at the same post-withdrawal time points in order to 
evaluate possible similar biphasic effects of NOP activation on stress-induced reinstatement 
of alcohol seeking.
Stress-induced reinstatement in vehicle-treated rats did not differ as a function of ethanol 
history in the 1-week post-withdrawal test, similar to the absence of differences in ethanol 
self-administration between nondependent and postdependent rats. At first glance these data 
seem inconsistent with previous findings (Liu and Weiss, 2002) showing an enhancement of 
stress-induced reinstatement in post-dependent versus non-dependent rats. However, in the 
Liu et al. study, reinstatement was tested 2 – 3 weeks after completion of ethanol 
withdrawal, a time corresponding closely to the 3-weeks time point in the present study. 
Consistent with this time line, higher reinstatement levels were observed also in the present 
study 3 weeks post-dependence. Thus, despite differences in dependence induction and 
extinction training procedures, the present study reproduced the enhanced responsiveness to 
stress after 3 weeks of abstinence originally reported by Liu et al.
MT-7716 significantly attenuated the effects of footshock at both post-withdrawal time 
points and, as in the case of self-administration, did so selectively in ethanol postdependent 
rats.
The selective effects of MT-7716 on ethanol self-administration and reinstatement in 
postdependent rats are likely to be linked to neuroadaptive changes in the N/OFQ system 
that develop as a result of ethanol intoxication and withdrawal and convey or enhance 
sensitivity to NOP activation. Consistent with this hypothesis, are recent findings that have 
described that NOP gene expression in the bed nucleus of the stria terminalis (BNST) is 
enhanced in ethanol postdependent rats (Martin-Fardon et al., 2010). The BNST plays an 
important role in animal models of stress-induced reinstatement of drug seeking (Erb and 
Stewart, 1999; Silberman and Winder, 2013). Moreover, as determined in slice preparations, 
ethanol postdependent rats show changes in the effects of N/OFQ on GABA transmission in 
the central nucleus of the amygdala during the acute withdrawal, characterized by an 
enhancement in the ability of N/OFQ to decrease the facilitation of GABAA 
neurotransmission by ethanol (Roberto and Siggins, 2006). Notably, CeA 
electrophysiological recording also revealed that N/OFQ more potently attenuates CRF-
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induced facilitation of GABA neurotransmission compared to nondependent controls (Cruz 
et al., 2012). Although these electrophysiological data were obtained during acute 
withdrawal whereas the present findings were obtained during protracted withdrawal, these 
findings document that functional changes develop in the N/OFQ system as a result of 
ethanol dependence, and that this aspect can be characterized behaviorally (Martin-Fardon et 
al., 2010)
Overall, the present findings suggest that ethanol dependence leads to neuroadaptive 
alteration in the N/OFQ-NOP system. Nonetheless, the precise functional changes in this 
system underlying the effects of MT-7716 here remain unclear. For example, increased NOP 
gene expression in the BNST has been found in ethanol post-dependent Wistar rats after one 
and three weeks of ethanol withdrawal (Aujla et al., 2013). However, in the same study, ICV 
administration of N/OFQ was reported to produce anxiogenic-like actions after 3 weeks of 
withdrawal, in contrast with the current finding where MT-7716 prevented stress-induced 
reinstatement in postdependent animals only and at both one and three weeks withdrawal. 
On one hand, these differences may be explained by the fact that stress-induced 
reinstatement and anxiety are not necessarily regulated by the same neurocircuitry. On the 
other hand the discrepant behavioral effects of MT-7716 vs. N/OFQ may be due to a 
different pharmacological profile of these two NOP agonists (Teshima et al., 2005). This is, 
however, unlikely because recent findings show that MT-7716 has the same 
electrophysiological effects as N/OFQ on CeA GABA-ergic neurotransmission (Cruz et al., 
2012; Kallupi et al., 2014). Importantly, activation of NOP receptors in this area (and related 
regulation of GABAergic activity) is critical for the anxiolytic effect of N/OFQ 
(Ciccocioppo et al., 2014). Consistent with this evidence, we found that MT-7716 (0.3–1 
mg/kg; p.o) significantly increased open arm time on the elevated plus maze in a model of 
hangover-induced anxiety, confirming potent anxiolytic-like actions (Teshima, unpublished 
observations). Nonetheless, further thorough pharmacological characterization of MT-7716 
in comparison with N/OFQ will be required to understand overlap and differences in the 
behavioral actions of these molecules and to characterize the clinical potential of MT-7716.
The specific inhibition of alcohol drinking in postdependent rats following MT-7716 
parallels recent findings showing that administration of corticotropin-releasing factor (CRF) 
receptor-1 antagonists reduces alcohol consumption in post-dependent Wistar and in msP 
rats but not in nondependent stock rats (Ayanwuyi et al., 2013; Funk et al., 2007; Hansson et 
al., 2006; Sommer et al., 2008). Several studies have documented that N/OFQ acts as a 
functional antagonist of behavior controlled by extra-hypothalamic CRF1 receptors 
(Ciccocioppo et al., 2003). For example, ICV administration of N/OFQ prevented both the 
anorexic and anxiogenic effects of stress induced by central CRF administration 
(Ciccocioppo et al., 2003; Ciccocioppo et al., 2001). Thus, it is possible that, in addition to 
neuroadaptations of the N/OFQ system produced by dependence-inducing ethanol 
intoxication, functional interactions between MT-7716 and CRF1 receptors (as described for 
N/OFQ) may play a role in the differential effects of the MT-7716 in post-dependent vs. 
non-dependent rats observed here.
In conclusion, the results further confirm that NOP receptors participate in mediating 
alcohol reinforcement and stress-induced reinstatement of alcohol seeking and that these 
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receptors may represent a potential pharmacotherapeutic target to treat alcoholism. In 
particular, the “anti-stress” effects of MT-7716 suggest that blood brain barrier (BBB) 
penetrating NOP agonists may have substantial clinical potential as complements to 
presently available anti-craving pharmacotherapies (such as naltrexone), that are ineffective 
in preventing stress-induced alcohol seeking (Le et al., 1999; Liu and Weiss, 2002). Lastly, 
the findings illustrate the importance of studying NOP receptor function to better understand 
the neurobiology of alcohol abuse.
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Figure 1. 
A: Experimental protocol for ethanol dependence induction. Ethanol solution (final 
concentration 25% w/v) was intubated four times per day for 5 consecutive days in a total 
volume of 22 ml/kg/day. B: somatic withdrawal signs measured at the beginning of 
treatment day 5. Insert: Overall withdrawal severity (sum of somatic withdrawal scores 
across the five behavioural signs of ethanol withdrawal). ***p < 0.001 versus non-
dependent. VLR, ventromedial limb retraction.
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Figure 2. 
Effect of MT-7716 on alcohol-reinforced responses in ethanol non-dependent and post-
dependent Wistar rats. Animals self-administered alcohol on a fixed ratio 1 schedule in 30-
minute daily sessions in which each reinforced response resulted in the delivery of 0.1 ml of 
10% ethanol. Treatment with MT-7716 reduced operant responses for alcohol preferentially 
in post-dependent animals at both doses tested (*p<0.05 and ** p<0.01). Insert: re-
establishment of alcohol self-administration baseline across the three test days.
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Figure 3. 
A: Effect of MT-7716 on stress induced reinstatement of alcohol seeking in non-dependent 
and post-dependent rats 1 week after completion of ethanol dependence induction. Results 
are expressed as mean (±SEM) responses at the active and the inactive levers. ### p<0.01 
0.0 mg/kg vs last 3 days of extinction. B: Effect of MT-7716 on stress induced reinstatement 
of alcohol seeking in non-dependent and post-dependent rats 3 weeks after completion of 
ethanol dependence induction. ### p<0.01 0.0 vs last 3 days of extinction; § p<0.05 0.0 
mg/kg non-dependent vs 0.0 post-dependent.
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